Aroa Biosurgery is a privately held soft tissue repair company commercialising regenerative tissue substitutes for medical conditions where impaired healing leads to serious consequences for patients. We are headquartered in Auckland, New Zealand which serves as our global base for development and manufacturing.
We have a strong track record of growth and we have attracted venture investment from Movac, Sparkbox, K1W1, CureKid Ventures and the New Zealand Venture Investment Fund.
As a medical device company, we benefit from less technical uncertainty along with shorter development and regulatory approval timeframes which means that the company carries substantially lower risk than many life science companies.
Enquiries from professional and institutional investors and parties interested in future investment opportunities are welcome.